Dataset Information


Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases.

ABSTRACT: Limited neural input results in muscle weakness in neuromuscular disease because of a reduction in the density of muscle innervation, the rate of neuromuscular junction activation or the efficiency of synaptic transmission. We developed a small-molecule fast-skeletal-troponin activator, CK-2017357, as a means to increase muscle strength by amplifying the response of muscle when neural input is otherwise diminished secondary to neuromuscular disease. Binding selectively to the fast-skeletal-troponin complex, CK-2017357 slows the rate of calcium release from troponin C and sensitizes muscle to calcium. As a consequence, the force-calcium relationship of muscle fibers shifts leftwards, as does the force-frequency relationship of a nerve-muscle pair, so that CK-2017357 increases the production of muscle force in situ at sub-maximal nerve stimulation rates. Notably, we show that sensitization of the fast-skeletal-troponin complex to calcium improves muscle force and grip strength immediately after administration of single doses of CK-2017357 in a model of the neuromuscular disease myasthenia gravis. Troponin activation may provide a new therapeutic approach to improve physical activity in diseases where neuromuscular function is compromised.


PROVIDER: S-EPMC3296825 | BioStudies | 2012-01-01

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC3577798 | BioStudies
2013-01-01 | S-EPMC3865762 | BioStudies
2014-01-01 | S-EPMC4013064 | BioStudies
1000-01-01 | S-EPMC4260123 | BioStudies
2018-01-01 | S-EPMC6681065 | BioStudies
2015-01-01 | S-EPMC4404445 | BioStudies
2020-01-01 | S-EPMC7749611 | BioStudies
2017-01-01 | S-EPMC5659053 | BioStudies
1000-01-01 | S-EPMC6294157 | BioStudies
2013-01-01 | S-EPMC3598806 | BioStudies